| 2023-05-18 | Sale | Jazz Pharmaceuticals plc JAZZ | EVP & Chief Financial Officer | 6,000 0.0094% | $131.75 | $790,474 | -5.13% | |
| 2022-12-21 | Sale | Jazz Pharmaceuticals plc JAZZ | EVP & Chief Financial Officer | 2,635 0.0042% | $160.00 | $421,600 | -15.58% | |
| 2018-08-15 | Sale | Theravance Biopharma, Inc. TBPH | SVP, Chief Financial Officer | 83,078 0.1526% | $26.74 | $2.22M | -8.53% | |
| 2018-08-14 | Sale | Theravance Biopharma, Inc. TBPH | SVP, Chief Financial Officer | 4,408 0.0082% | $27.74 | $122,272 | -10.69% | |
| 2018-05-18 | Sale | Theravance Biopharma, Inc. TBPH | SVP, Chief Financial Officer | 20,000 0.0371% | $24.29 | $485,754 | +4.81% | |
| 2018-03-07 | Corcept Therapeutics Incorporated CORT | director | 9,000 0.0077% | $15.53 | $139,802 | -10.84% | ||
| 2018-03-06 | Corcept Therapeutics Incorporated CORT | director | 1,000 0.0009% | $15.30 | $15,300 | -8.81% | ||
| 2015-08-17 | Theravance Biopharma, Inc. TBPH | SVP, Chief Financial Officer | 10,000 0.0299% | $12.16 | $121,600 | +43.79% | ||
| 2015-08-13 | Theravance Biopharma, Inc. TBPH | SVP, Chief Financial Officer | 10,000 0.0303% | $12.19 | $121,900 | +44.73% |